High Expression of Osteopontin and CD44v6 in Odontogenic Keratocysts  by Wang, Yi-Ping & Liu, Bu-Yuan
286 J Formos Med Assoc | 2009 • Vol 108 • No 4
ORIGINAL ARTICLE
The odontogenic keratocyst (OKC) is a specific
type of odontogenic cyst with a parakeratotic epi-
thelial lining. It has been named newly as a kera-
tocystic odontogenic tumor by the WHO Working
Group because of its aggressive clinical behavior
and neoplastic nature.1,2 Occurrence of multiple
OKCs in the jawbone has been noted in some pa-
tients, especially those with Gorlin syndrome.
OKCs are well known for their bone destructive
behavior and high recurrence rate after surgical
treatment.3 However, the molecular mechanisms
that result in local aggressive behavior and high
osteolytic ability of OKCs are unclear.
Osteopontin (OPN) is an extracellular matrix
protein that was found initially in mineralized
tissue with RGD (Arg-Gly-Asp) tripeptide.4 It is a
member of the SIBLING (Small Integrin-Binding
LIgand, N-linked Glycoprotein) family.5,6 OPN
is encoded by a gene designated as SPP1 at
chromosome 4q21–23. It possesses high affinity
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tumor cell motility, migration, invasion and spread. This study assessed the possible contribution of OPN,
integrin αv and CD44v6 to the local aggressive behavior and osteolytic ability of OKCs.
Methods: We used an immunohistochemical method to examine the expression of OPN, integrin αv and
CD44v6 in tissue sections of 20 OKCs, eight DCs and 10 RCs.
Results: We found strong cytoplasmic OPN immunostaining in lining epithelial cells of 8 of 20 OKCs but not
in any DCs and RCs. Positive OPN staining was also noted in the subepithelial connective tissue of four
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to hydroxyapatite and has been shown to pro-
mote cell attachment and migration by serving
as an attachment substrate for αv-containing in-
tegrins, especially integrin αvβ3.7–10 OPN is also a
chemoattractant to precursors of osteoclasts and
can modulate osteoclast activity.7,8,11,12 The expres-
sion of OPN is correlated with malignant trans-
formation of cells and metastasis in several human
cancers, especially in those with osteotropic ten-
dency such as breast and prostate carcinomas.13
The cell membrane protein CD44v6 is another
receptor for OPN and the interaction between
these two molecules plays a role in promoting
cell motility.14–17 Furthermore, a recent study has
indicated that the OPN–CD44v6 interaction pro-
motes integrin activation.18 Although OKCs can
cause prominent jawbone destruction, expression
of OPN and its receptors integrin αv and CD44v6
in OKCs, and the roles of these three proteins in-
volved in bone destruction and local aggressive
behavior of OKCs, have not been established.
Binding of OPN to osteoclast cell membrane
receptor integrin αv can activate osteoclasts and
increase their osteolytic activity. Furthermore,
binding of OPN to the tumor cell membrane re-
ceptor CD44v6 can enhance tumor cell motility,
migration, invasion and spread. Therefore, in this
study, we assessed the expression of OPN and its
receptors integrin αv and CD44v6 in OKCs and
in two types of non-neoplastic odontogenic cysts,
dentigerous cysts (DCs) and radicular cysts (RCs),
to investigate the possible contribution of OPN,
integrin αv and CD44v6 to the local aggressive
behavior and osteolytic ability of OKCs.
Methods
Patients and specimens
After approval by the Hospital Review Board, we
obtained formalin-fixed, paraffin-embedded tissue
blocks from 20 patients (15 men, 5 women; mean
age, 30 years; age range, 14–55 years) with OKCs;
eight patients (4 men, 4 women; mean age, 25
years; age range, 18–29 years) with DCs; and 10 pa-
tients (6 men, 4 women; mean age, 32 years; age
range, 21–45 years) with RCs from the files of the
Department of Oral Pathology, National Taiwan
University Hospital. Diagnosis of the OKCs, DCs
and RCs was based on histological examination
of hematoxylin-and-eosin-stained tissue sections.
All OKC patients received both incisional biopsy
and total surgical intervention (enucleation or
curettage) of their lesions at the Department of
Oral and Maxillofacial Surgery, National Taiwan
University Hospital, from 1999 to 2003. OKCs
were all primary lesions. The OKC patients were
followed for 52–77 months (mean, 69 months).
Ten of them developed recurrent lesions at 5–75
months after surgical intervention. Specimens of
eight DCs and 10 RCs were obtained from total
surgical excision of the lesions and used for com-
parison of expression of OPN, integrin αv and
CD44v6. None of the DCs and RCs recurred after
a follow-up period ranging from 56 to 70 months
(mean, 63 months).
Immunohistochemical staining for OPN,
integrin av and CD44v6
Four-micrometer tissue sections were cut, de-
paraffinized in xylene, rehydrated in descending
alcohol, and rinsed in running water for 10 min-
utes. For staining of CD44v6, sections were boiled
in 0.1 M citrate buffer (pH 6.0) in a microwave
oven (580 W) for 10 minutes to retrieve anti-
genicity. Antigen retrieval was not performed for
staining of OPN and integrin αv. The endoge-
nous peroxidase activity was blocked by immers-
ing the sections in 3% H2O2 in methanol for 30
minutes. After washing in 10 mM Tris-buffered
saline (TBS), pH 7.4, sections were incubated with
5% normal goat serum for 30 minutes to block
nonspecific binding. Sections were then incubated
overnight at 4°C with the appropriate dilutions
of primary antibodies, including rabbit anti-human
OPN polyclonal antibody at a 1:1000 dilution
(Calbiochem, San Diego, CA, USA), mouse anti-
human integrin αv monoclonal antibody at a 1:50
dilution (Santa Cruz Biotechnology, Santa Cruz,
CA, USA), and mouse anti-human CD44v6 mono-
clonal antibody at a 1:50 dilution (Novocastra
Laboratories, Newcastle, UK). After washing in TBS,
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sections were treated with biotinylated goat anti-
mouse IgG (for those sections stained with mouse
primary antibodies) or biotinylated goat anti-rabbit
IgG (for those sections stained with rabbit primary
antibodies) and subsequently with a streptavidin-
peroxidase conjugate (Dako Corp., Copenhagen,
Denmark) for 20 minutes at room temperature.
Diaminobenzidine hydrochloride (0.02%) con-
taining 0.03% H2O2 was used as a chromogen to
visualize the peroxidase activity. The preparations
were lightly counterstained with hematoxylin,
mounted with Permount, and examined by light
microscopy. Bone trabeculae included in the sec-
tions served as the positive and internal controls
for OPN. Sections of a peripheral giant cell granu-
loma were used as positive controls for integrin
αv.19 Normal skin tissue sections were used as pos-
itive controls for CD44v6.20 Tissue sections stained
with TBS instead of primary antibody were used
as negative controls.
In this study, only the percentage of cells that
showed positive cytoplasmic or membranous stain-
ing, but not the intensity of staining, was quantified,
as suggested by Hall and Lane.21 The proportion
of positively stained cells in all lining epithelial
cells (designated as labeling index, LI) of each sec-
tion was determined and recorded as follows: 3+,
51–100%; 2+, 31–50%; 1+, 11–30%; and −, ≤ 10%
or none of lining epithelial cells were positively
stained in the cytoplasm, or on the cell membrane.
Results
Immunohistochemical staining for OPN
Positive control sections of OPN revealed strong
immunostaining in the cytoplasm of osteoblasts
and in the osteoid tissue at the site of new bone
formation (Figure 1A). Focal cytoplasmic OPN
staining was also noted in osteocytes in the lacunae.
Eight (40%) of the 20 OKCs demonstrated positive
cytoplasmic OPN immunostaining in lining epi-
thelial cells (Table). Notably, OPN immunostaining
was stronger in the upper- than in the lower-half
lining epithelial cells (Figure 1B). LI was 3+ for
six and 2+ for two OKC cases. Furthermore, focal
OPN staining was observed in subepithelial con-
nective tissues of 4 of 20 OKCs, which also showed
intraepithelial OPN staining. None of the DCs
(Figure 1C) and RCs (Figure 1D) showed positive
OPN staining in lining epithelial cells (Table).
Immunohistochemical staining for integrin av
The positive control sections of the peripheral
giant cell granuloma revealed strong membra-
nous integrin αv staining in osteoclast-like giant
cells (Figure 2A). Osteoclasts in all our tissue sec-
tions also showed moderate to strong integrin αv
staining on the cell membrane. None of the OKCs
were positive for integrin αv in the lining epithe-
lial cells (Table and Figure 2B). However, all the
DCs (Figure 2C) and RCs (Figure 2D) showed
diffuse, strong membranous and focal cytoplasmic
integrin αv staining in nearly all lining epithelial
cells. The strongest integrin αv immunoreactivity
was found on the cell membrane of lining epithe-
lial cells facing the cystic cavity. However, the hyper-
plastic lining epithelial ridges extending into the
inflamed fibrous connective tissue wall of DCs and
RCs partially lost their expression of integrin αv
(data not shown).
Immunohistochemical staining for CD44v6
Diffuse and strong membranous CD44v6 staining
was found on the basal and spinous cells of the
positive control skin sections, except in the basal
keratinocyte cell membrane facing the basement
membrane (Figure 3A). The sweat gland ductal
cells in the dermis were also positive for CD44v6.
Diffuse and strong membranous CD44v6 staining
was also observed in nearly all lining epithelial
cells in the OKCs (Figure 3B), DCs (Figure 3C) and
RCs (Figure 3D and Table). However, the superfi-
cial parakeratotic cells of the lining epithelium of
OKCs showed no membranous CD44v6 staining
(Figure 3B).
Discussion
OPN was found originally to be associated with
bone remodeling and to play an inductive role in
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mineralization.22 OPN can increase cell adhesion
and migration in various cell types, especially cells
of the macrophage/osteoclast lineage.23 Moreover,
OPN can bind and activate matrix metallopro-
teinase 3.24 OPN can also trigger integrin-mediated
signal transduction, which, in turn, leads to osteo-
clast activation. In addition, OPN is able to reduce
macrophage nitric-oxide-mediated cytotoxicity,
and protect tumor cells from immune surveil-
lance.25,26 It has also been demonstrated that OPN
can block the formation of membrane attack com-
plex by recruiting complement factor H, a pivotal
negative regulator of complement-mediated cell
lysis.27 This can also improve the survival of tumor
cells. OPN can enhance tumor cell migration, inva-
sion and spread, activate osteoclasts, and protect
A B
DC
Figure 1. Immunohistochemical staining for osteopontin (OPN). (A) A positive control section showing strong OPN 
immunostaining in osteoblasts in an active bone forming site. (B) Odontogenic keratocyst demonstrating moderate 
cytoplasmic OPN staining in lining epithelial cells. Notably, OPN immunostaining was stronger in the upper- than in 
the lower-half lining epithelial cells. (C) Dentigerous cyst and (D) radicular cyst revealing no OPN immunoreactivity in 
the lining epithelium. (Original magnification: A, 120×; B–D, 200×.)
Table. Immunohistochemical staining for osteopontin (OPN), integrin αv and CD44v6 in odontogenic
keratocysts (OKCs), dentigerous cysts (DCs), and radicular cysts (RCs)*
Histologic type of OPN Integrin αv CD44v6 
odontogenic cyst Positive cases Positive cases Positive cases
OKC (n = 20) 8 (40) 0 (0) 20 (100)
DC (n = 8) 0 (0) 8 (100) 8 (100)
RC (n = 10) 0 (0) 10 (100) 10 (100)
*Data presented as n (%).
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cells from immune-mediated cytotoxicity; there-
fore, elevated expression of OPN in lining epithelial
cells and subepithelial connective tissues of OKCs
can explain, at least partially, why OKCs have local
aggressive behavior and high osteolytic ability.
The present study showed positive OPN im-
munostaining in 8 (40%) of 20 OKCs but not in
any of the DCs and RCs. OPN protein expression
was mainly discovered in the upper rather than
lower half of the lining epithelial cells. OPN im-
munostaining was also found in subepithelial
connective tissue of 4 (20%) of 20 OKCs. Our
findings suggest that the OPN protein is probably
synthesized and secreted by the upper-half lining
epithelial cells, picked up by the lower-half lin-
ing epithelial cells, and released into the subep-
ithelial connective tissues of OKCs via basal cells,
by transcytosis. Further studies, such as in situ hy-
bridization for OPN mRNA, are necessary to elu-
cidate this hypothesis.
The present study also examined the expression
of integrin αv and CD44v6 in OKCs. OPN is known
to interact with αv-containing integrins, such as
αvβ3, αvβ1, and αvβ5.28 Binding of OPN to cell
membrane receptor integrin αv on osteoclasts can
activate the osteoclasts and increase their oste-
olytic activity.29,30 Furthermore, OPN can also bind
CD44v6, which has been shown to be another
class of OPN receptor. Binding of OPN to tumor
cell membrane receptor CD44v6 can enhance
tumor cell motility10,17,18,31 and increase the im-
mune adaptation of OPN-expressing cells.23,25–27
Concomitant expression of OPN and CD44v6 in
lining epithelial cells of OKCs indicates the exis-
tence of autocrine/paracrine mechanisms for OPN
in OKCs. Expression of CD44v6 has been proven
to enhance the metastatic potential of malignant
tumors.32,33 Tumor-cell-expressed SIBLING pro-
teins (e.g. OPN and bone sialoprotein) are seen
frequently in osteotrophic metastatic lesions such
A B
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Figure 2. Immunohistochemical staining for integrin αv. (A) A positive control section of a peripheral giant cell granu-
loma revealing a strong integrin αv staining on the cell membrane of multinucleated giant cells. (B) No integrin αv
immunostaining was seen in lining epithelial cells of an odontogenic keratocyst. However, diffuse and strong membranous
integrin αv immunostaining was observed in lining epithelial cells of a: (C) dentigerous cyst; and (D) radicular cyst.
(Original magnification: A and C, 200×; B and D, 100×.)
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as breast and prostate cancers.13 The OPN-CD44-
ERM complex is proposed to enhance cell motil-
ity.34,35 Through this interaction, OPN can help
the invasion and spread of OKC lining epithelial
cells into the surrounding cancellous bone. In the
present study, integrin αv and CD44v6 were ex-
pressed by the lining epithelial cells of DCs and
RCs. Since no OPN was expressed by epithelial and
connective tissue cells in DCs and RCs, there was
no OPN-mediated function that could be executed
in DCs and RCs.
OPN is a chemoattractant for precursors of
osteoclasts. Binding of OPN to osteoclast cell mem-
brane receptor integrin αv can activate the osteo-
clasts and increase their osteolytic activity. In
addition, binding of OPN to OKC lining epithe-
lial cell membrane receptor CD44v6 can enhance
the motility, migration, invasion and spread of lin-
ing epithelial cells into the surrounding cancellous
bone. Therefore, we suggest that the local aggressive
behavior and high osteolytic ability of OKCs in
the jawbone can be explained, at least partially,
by high expression of OPN and CD44v6 in lining
epithelial cells of OKCs and high expression of
intergrin αv in osteoclasts.
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